首页|痰热清注射液辅助更昔洛韦治疗呼吸道合胞病毒性肺炎患儿的效果观察

痰热清注射液辅助更昔洛韦治疗呼吸道合胞病毒性肺炎患儿的效果观察

扫码查看
目的 探讨痰热清注射液辅助更昔洛韦注射液治疗小儿呼吸道合胞病毒性肺炎(Respiratory syncytial virus pneumonia,RSVP)的效果观察.方法 选择2013年2月~2016年1月浙江舟山医院接诊的145例RSVP小儿患者,按照不同的用药方案,分为2组,对照组71例,采用更昔洛韦注射液治疗;研究组74例,在对照组用药的基础上,加以痰热清注射液治疗.分别于治疗前、治疗7 d后及14 d后,比较2组患儿血气指标pH、PaO2、PaCO2的水平变化,分别记录患儿肺部啰音、喘息、发热、咳嗽、哮鸣音消失时间及不良反应发生情况.结果 研究组用药7、14 d后血气指标pH分别为(7.38±0.21)和(7.41±0.26),PaO2分别为(96.45±4.06)mmHg和(98.84±5.27)mmHg,均显著高于对照组(P<0.05);PaCO2分别为(45.02±4.23)mmHg和(41.26±3.16)mmHg均明显低于对照组(P<0.05);研究组肺部啰音消退时间为(4.47±1.06)天、哮鸣音消退时间为(5.03±0.43)天、喘息消退时间为(4.89±0.72)天、发热消退时间为(2.46±0.32)天、咳嗽消退时间为(8.41±1.54)天,均明显低于对照组(P<0.05);研究组不良反应率8.11%显著低于对照组21.13%(P<0.05).结论 痰热清注射液辅助更昔洛韦治疗RSVP患儿疗效显著,可大幅缩短患儿喘息、哮鸣音、肺部啰音等临床指证消退的时间,改善患儿血气指标水平,减少不良反应发生.
Effect of Tanreqing injection assisted Ganciclovir on children with respiratory syncytial virus pneumonia
Objective To investigate the effect of Tanreqing injection assisted ganciclovir on children with respiratory syncytial virus pneumonia . Methods 145 cases of RSVP pediatric patientsin from February 2013 to January 2016 in our hospital were retrospectively chosen,according to different drug regimen,they were divided into two groups,the contronl group of 71 cases with ganciclovir injection treatment and study group of 74 cases,with Tanreqing injection treatment on the basis of the contronl group.The blood gas analysis was performed on the arterial blood of the two groups before treatment and 7 and 14 days after continuous administration.The changes of blood gas indexes (pH,PaO2,PaCO2) were compared.The lung rales, wheezing, fever, cough, wheeze disappearance of time and side effects of the children were recorded.Results After 7 and 14 days of treatment, the Ph of blood gas parameters in the study group were (7.38 ±0.21) and (7.41 ±0.26), the level of PaO2 were (96.45 ±4.06) mmHg and (98.84 ± 5.27) mmHg,which were significantly higher than those of the control group (P<0.05);the level of PaCO2 in the study group were(45.02 ±4.23) mmHg and (41.26 ±3.16) mmHg, which were significantly lower than those in the contronl group (P<0.05).The rale resorption time in the study group was (4.47 ±1.06) days, the duration of wheezing subsided was (5.03 ±0.43) days, the duration of wheezing was (4.89 ±0.72) days, the duration of fever subsided was (2.46 ±0.32) days, the duration of cough was (8.41 ±1.54) days,were significantly lower than the control group(P<0.05).The adverse reaction rate in the study group was 8.11%, significantly lower than that in the control group 21.13%(P<0.05).Conclusion The combination of Tanreqing injection combined with ganciclovir has a good effect on children with RSVP , and can significantly shorten the time of clinical evidences such as wheezing, wheezing and pulmonary rales, and improve the blood gas level in children,reduce adverse reactions.

Tanreqing injectionGanciclovirrespiratory syncytial virus pneumoniablood gas index

王良军、张海瑛、王浙梅

展开 >

浙江舟山医院 儿科,浙江 舟山 316021

痰热清注射液 更昔洛韦 呼吸道合胞病毒性肺炎 血气指标

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(2)
  • 11
  • 9